Gabi Kaminski Schierle, who heads biological research activities in the Laser Analytics Group, has been appointed as Lecturer in Molecular Biotechnology at this department, with effect from 1 July 2015 - many congratulations!
Gabi heads molecular biology activities in the Laser Analytics Group and a team of currently 11 people. She has built up a comprehensive research portfolio in the neurosciences, and applies a whole range of biophysical techniques in her research to unravel molecular mechanisms of neurodegeneration during Alzheimer's and Parkinson's Diseases. She started her career with a degree in Biology at the Université de Fribourg, Switzerland, before embarking on a PhD in medical research at the Wallenberg Neuroscience Centre, at the University of Lund, in Sweden.
In Sweden, Gabi developed a new method to improve the survival rate of dopaminergic neurones transplanted into patients suffering from Parkinson's disease, which was at the time used as a successful clinical therapy for symptomatic relief from motor disorders. This research won her several international prizes, including a Science Parkinson's Disease Foundation science award.
She came to Cambridge as Marie Curie Fellow, and gained a Wellcome Trust early career award to begin research into strategies for molecular therapies against Parkinson's and Alzheimer's, the focus of her current research. She introduced the use of high resolution imaging methods into the field and pioneered the use of high resolution microscopy to probe protein misfolding reactions.
Gabi acts as a role model in combining family life with an active scientific career. We are delighted at this recognition of her excellence in research and look forward to many exciting future discoveries!